africa ncd open lab

9
Africa NCD Open Lab H3Africa consortium meeting Zambia May 2015 SA/CR/0001/15

Upload: others

Post on 24-Oct-2021

8 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Africa NCD Open Lab

Africa NCD Open Lab

H3Africa consortium meeting

Zambia May 2015

SA/CR/0001/15

Page 2: Africa NCD Open Lab

GSK Africa Strategy

May 2015Africa NCD Open Lab 2

VISION: Build an integrated and local African healthcare company with the

capabilities, people, and portfolio to reach patients in Sub-Saharan Africa

Research African

Medicines

forAfrican

People

Manufacture

and Supply

Commercial

Presence

Talent Infrastructure

Page 3: Africa NCD Open Lab

Africa NCD Open Lab – concept overview

May 2015Africa NCD Open Lab 3

World Class

Academic

Groups

Funding

partners

African Research

Centres

Access to full range of GSK capabilities

Scientific Advisory Board

Training Program

GSK R&D UK Lab

Page 4: Africa NCD Open Lab

Progress to date

Page 5: Africa NCD Open Lab

External Scientific Advisory Board

May 2015Africa NCD Open Lab 5

Dwomoa Adu

Ghana

Moffat Nyirenda

Malawi

Tumani Corrah

The Gambia

Corey Casper

USA

Bongani Mayosi

South Africa

Julie Makani

Tanzania

Jean Claude Mbanya

Cameroon

Nicola Mulder

South Africa

Nelson Sewankambo

Uganda

Gerald Yonga

Kenya

Heather Zar

South Africa

Page 6: Africa NCD Open Lab

Call for proposals – kick-starting research efforts

Africa NCD Open Lab 6

GSK call

• 8 SSA countries in scope

• Up to £4m available together with potential access to GSK expertise

• Call closed Jan 2015 • Proposals now under

review• Aim to start first

projects 2H2015

GSK, MRC South Africa, MRC UK call

• Focus is on South Africa

• Up to £5m available (£4m from external partners) together with potential access to GSK expertise

• Proposals must have relevance to wider SSA

• Call closes 28 June 2015

May 2015

Page 7: Africa NCD Open Lab

Africa NCD Open Lab – Training, Centres

May 2015Africa NCD Open Lab 7

World Class

Academic

Groups

Funding

partners

African Research

Centres

Access to full range of GSK capabilities

Scientific Advisory Board

Training Program

GSK R&D UK Lab

Page 8: Africa NCD Open Lab

H3Africa - Possible Areas for Collaboration

– Translating H3Africa research findings into potential

therapeutics

– Pharmacogenomics (PGx) opportunities:

– ADME genetic variation

– ADME activity variation

– PGx insights in existing H3A projects

– GSK PGx contributions:

– Design, analysis and interpretation of PGx data

– Drug metabolism and drug transporter expertise

May 2015Africa NCD Open Lab 8

Page 9: Africa NCD Open Lab

Thank You